Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 47 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Lumbar fusion | 45 | 1,762−4.7%/yr | −4.7%/yr | 3.51.1× | 1% | 1,970 in 2030+1.9%/yr |
| Decompression & minimally invasive spine | 44 | 1,608−8.9%/yr | −8.9%/yr | 3.21.0× | 1% | 1,650 in 2030+0.4%/yr |
| Kyphoplasty & vertebroplasty | 16 | 1,356−6.7%/yr | −6.7%/yr | 2.81.6× | 48% | 1,260 in 2030−1.2%/yr |
| Cervical fusion & disc arthroplasty | 28 | 913−6.1%/yr | −6.1%/yr | 1.81.1× | 0% | 980 in 2030+1.2%/yr |
| SI joint fusion | 9 | 370+24%/yr | +24%/yr | 0.72.2× | 54% | 610 in 2030+8.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 201 | 53,727−3%/yr | −3%/yr | 106.70.9× | 40% | 59,200 in 2030+1.6%/yr |
| Skin substitutes & wound grafts | 48 | 11,719+21%/yr | +21%/yr | 16.61.5× | 72% | 19,200 in 2030+8.6%/yr |
| Bone graft & orthobiologics | 13 | 397−18%/yr | −18%/yr | 0.81.2× | 1% | 430 in 2030+1.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 78 | 8,975+3.6%/yr | +3.6%/yr | 17.81.3× | 65% | 11,900 in 2030+4.8%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 21 | 1,024+2.9%/yr | +2.9%/yr | 2.01.4× | 28% | 1,160 in 2030+2.1%/yr |
| Spinal cord & DRG stimulation | 21 | 734−3%/yr | −3%/yr | 1.41.6× | 45% | 850 in 2030+2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 19 | 2,386−5.2%/yr | −5.2%/yr | 4.70.7× | 47% | 3,400 in 2030+6.1%/yr |
| Dialysis access | 31 | 1,548−12%/yr | −12%/yr | 3.30.6× | 12% | 1,570 in 2030+0.3%/yr |
| Superficial venous ablation | 15 | 1,005−11%/yr | −11%/yr | 2.00.3× | 28% | 1,140 in 2030+2.2%/yr |
| Carotid revascularization | 16 | 757−4.9%/yr | −4.9%/yr | 1.51.2× | 0% | 700 in 2030−1.3%/yr |
| Thrombectomy, IVC filters & venous stents | 3 | 598+2.9%/yr | +2.9%/yr | 1.20.7× | 0% | 860 in 2030+6.2%/yr |
| Aortic endografts (EVAR/TEVAR) | 3 | 167−14%/yr | −14%/yr | 0.30.7× | 0% | 190 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 30 | 2,570−3.5%/yr | −3.5%/yr | 5.60.9× | 0% | 2,900 in 2030+2.1%/yr |
| Cholecystectomy & appendectomy | 64 | 2,262−6.3%/yr | −6.3%/yr | 4.81.1× | 0% | 2,230 in 2030−0.3%/yr |
| Colorectal resection | 7 | 875−4%/yr | −4%/yr | 1.81.1× | 0% | 740 in 2030−2.7%/yr |
| Antireflux & hiatal hernia surgery | 4 | 319−1.5%/yr | −1.5%/yr | 0.70.8× | 0% | 340 in 2030+0.8%/yr |
| Breast reconstruction | 2 | 110−8.8%/yr | −8.8%/yr | 0.20.5× | 0% | 120 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 58 | 2,956−0.1%/yr | −0.1%/yr | 6.11.2× | 1% | 3,150 in 2030+1.1%/yr |
| BPH procedures | 41 | 2,246−10%/yr | −10%/yr | 4.60.9× | 36% | 2,140 in 2030−0.8%/yr |
| Incontinence, prolapse & sacral neuromodulation | 26 | 1,344−7%/yr | −7%/yr | 2.81.0× | 10% | 1,310 in 2030−0.5%/yr |
| Hysterectomy, hysteroscopy & ablation | 7 | 1,055−0.1%/yr | −0.1%/yr | 2.30.9× | 0% | 1,240 in 2030+2.7%/yr |
| Prostatectomy & nephrectomy | 10 | 673+0.8%/yr | +0.8%/yr | 1.51.2× | 0% | 770 in 2030+2.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 17 | 2,185+7.6%/yr | +7.6%/yr | 4.50.9× | 69% | 3,570 in 2030+8.5%/yr |
| Ear tubes & middle ear surgery | 4 | 232−2.9%/yr | −2.9%/yr | 0.51.5× | 12% | 150 in 2030−6.6%/yr |
| Sleep apnea & airway implants | 4 | 126+26%/yr | +26%/yr | 0.31.1× | 0% | 180 in 2030+5.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 56 | 2,408+1%/yr | +1%/yr | 5.20.8× | 2% | 2,580 in 2030+1.1%/yr |
| Tumor & fibroid embolization | 2 | 185+1.4%/yr | +1.4%/yr | 0.40.7× | 22% | 180 in 2030−0.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 89 | 11,902+33%/yr | +33%/yr | 24.20.9× | 84% | 19,400 in 2030+8.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 41 | 2,342−5.8%/yr | −5.8%/yr | 5.00.9× | 3% | 2,290 in 2030−0.4%/yr |
| LAA occlusion & loop recorders | 50 | 1,926+8.2%/yr | +8.2%/yr | 3.61.0× | 8% | 3,560 in 2030+11%/yr |
| EP ablation | 23 | 1,684+4.1%/yr | +4.1%/yr | 3.00.8× | 0% | 2,960 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 89 | 4,003−9.8%/yr | −9.8%/yr | 7.01.2× | 3% | 3,940 in 2030−0.2%/yr |
| Structural heart (TAVR, TEER) | 38 | 772+1.6%/yr | +1.6%/yr | 1.40.9× | 0% | 1,030 in 2030+4.9%/yr |
| Mechanical circulatory support | 0 | 231−9.9%/yr | −9.9%/yr | 0.50.8× | 0% | 240 in 2030+0.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 4 | 180+1.4%/yr | +1.4%/yr | 0.40.9× | 0% | 140 in 2030−3.7%/yr |
| Aneurysm & intracranial embolization | 2 | 164+3.5%/yr | +3.5%/yr | 0.30.8× | 0% | 450 in 2030+18%/yr |
| DBS & VNS | 3 | 152+4.2%/yr | +4.2%/yr | 0.31.0× | 0% | 150 in 2030−0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 85 | 29,510−2.8%/yr | −2.8%/yr | 60.01.0× | 81% | 28,700 in 2030−0.5%/yr |
| Vitreoretinal surgery | 14 | 1,019−4.8%/yr | −4.8%/yr | 2.10.8× | 77% | 1,020 in 2030+0.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 189 | 42,798−5.6%/yr | −5.6%/yr | 91.00.8× | 28% | 41,600 in 2030−0.5%/yr |
| Bronchoscopy & lung nodule | 14 | 974+2.6%/yr | +2.6%/yr | 2.00.6× | 0% | 2,260 in 2030+15%/yr |
| ERCP & endoscopic ultrasound | 13 | 913−5.4%/yr | −5.4%/yr | 1.90.6× | 0% | 1,080 in 2030+2.9%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.